Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin in Cocaine Dependence
NCT03266939Phase 1Withdrawn
- Sponsor
- McLean Hospital
- Start
- Oct 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lorcaserin in cocaine dependence (2 arms), sponsored by McLean Hospital. Primary endpoint: Influence of lorcaserin on fMRI measured brain-reactivity to drug cues. Planned start Oct 2018; status: withdrawn.
02
Drugs
lorcaserin
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT03266939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266939.